Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biofrontera (BFRI) Cash from Financing Activities (2020 - 2025)

Biofrontera (BFRI) has 5 years of Cash from Financing Activities data on record, last reported at $4.0 million in Q4 2024.

  • For Q4 2024, Cash from Financing Activities fell 39.68% year-over-year to $4.0 million; the TTM value through Sep 2025 reached $9.0 million, down 48.36%, while the annual FY2024 figure was $14.8 million, 76.38% up from the prior year.
  • Cash from Financing Activities reached $4.0 million in Q4 2024 per BFRI's latest filing, up from -$298000.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $43.8 million in Q4 2021 and bottomed at -$298000.0 in Q3 2024.
  • Average Cash from Financing Activities over 5 years is $7.5 million, with a median of $4.5 million recorded in 2020.
  • Peak YoY movement for Cash from Financing Activities: skyrocketed 3926.45% in 2022, then plummeted 150.42% in 2024.
  • A 5-year view of Cash from Financing Activities shows it stood at $4.3 million in 2020, then soared by 910.35% to $43.8 million in 2021, then plummeted by 89.44% to $4.6 million in 2022, then surged by 45.01% to $6.7 million in 2023, then tumbled by 39.68% to $4.0 million in 2024.
  • Per Business Quant database, its latest 3 readings for Cash from Financing Activities were $4.0 million in Q4 2024, -$298000.0 in Q3 2024, and $5.3 million in Q2 2024.